InterCure Ltd.
General ticker "INCR" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $54.3M (TTM average)
InterCure Ltd. does not follow the US Stock Market performance with the rate: -2.0%.
Estimated limits based on current volatility of 2.3%: low 5.18$, high 5.43$
Factors to consider:
- Total employees count: 145 (+45.0%) as of 2025
Short-term INCR quotes
Long-term INCR plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | ILS355.55MM | ILS238.84MM | ILS270.20MM |
| Operating Expenses | ILS397.12MM | ILS306.05MM | ILS263.47MM |
| Operating Income | ILS-41.57MM | ILS-67.21MM | ILS6.73MM |
| Non-Operating Income | ILS-19.72MM | ILS-20.11MM | ILS-50.84MM |
| Interest Expense | ILS24.22MM | ILS20.64MM | ILS19.66MM |
| R&D Expense | ILS0.39MM | ILS0.41MM | ILS0.39MM |
| Income(Loss) | ILS-61.28MM | ILS-87.32MM | ILS-44.10MM |
| Taxes | ILS2.25MM | ILS-14.53MM | ILS-7.32MM |
| Net Income(Loss)* | ILS-61.96MM | ILS-67.80MM | ILS-35.71MM |
| Stockholders Equity | ILS455.11MM | ILS396.97MM | ILS396.52MM |
| Inventory | ILS106.29MM | ILS125.33MM | ILS108.06MM |
| Assets | ILS786.61MM | ILS762.57MM | ILS690.55MM |
| Operating Cash Flow | ILS-53.63MM | ILS-66.93MM | ILS16.84MM |
| Capital expenditure | ILS2.62MM | ILS4.38MM | ILS3.55MM |
| Investing Cash Flow | ILS4.77MM | ILS17.69MM | ILS-1.99MM |
| Financing Cash Flow | ILS-82.89MM | ILS26.45MM | ILS-46.66MM |
| Earnings Per Share** | ILS-6.80 | ILS-7.10 | ILS-3.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.